Tumor Microenvironment Research

3 researchers across 2 institutions

3 Researchers
2 Institutions
2 Grant PIs
2 High Impact

Research in this area investigates the complex ecosystem surrounding tumors, known as the tumor microenvironment. Scientists explore how non-cancerous cells, blood vessels, signaling molecules, and the immune system interact with and influence tumor growth, progression, and response to therapy. Studies employ techniques such as molecular biology, cell culture, advanced microscopy, and animal models to understand these intricate cellular and molecular dynamics. Key areas of focus include the role of immune cells in suppressing or promoting cancer, the development of new blood vessels that feed tumors, and the extracellular matrix that supports tumor architecture.

This work has direct relevance to Arkansas's public health initiatives, particularly concerning cancer incidence and mortality rates within the state. Understanding the tumor microenvironment can lead to the development of more effective cancer treatments and preventative strategies tailored to the needs of Arkansas populations. Furthermore, advancements in this field can foster innovation in the state's growing biotechnology and pharmaceutical sectors, creating economic opportunities and enhancing the state's capacity for medical research and development.

This research area draws upon expertise in immune response, inflammation, cancer treatment, pharmacology, and metabolism. Collaborations extend across multiple institutions in Arkansas, fostering a multidisciplinary approach that integrates diverse scientific perspectives to address complex cancer biology challenges.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Behjatolah Monzavi‐Karbassi UAMS 24 1,603 Grant PI High Impact
Narasimhan Rajaram University of Arkansas 24 1,875 Grant PI High Impact
Thomas Kelly Jr UAMS 0 0

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
29,112 works in 2025
+11.8% CAGR 2018–2025
Leadership concentration
8.6% held by global top 5 institutions
Fragmented HHI 49
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2025 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 6,651
  2. 2 Dana-Farber Cancer Institute 4,653
  3. 3 Memorial Sloan Kettering Cancer Center 4,578
  4. 4 Harvard University 4,033
  5. 5 Johns Hopkins University 2,929

Researchers with Federal Grants

Browse All 3 Researchers in Directory